We would like to thank every single participant who took part in this year’s ILC, held 23–26 June 2021. The event brought together almost 6,500 delegates from over 100 countries, who took part in 155 sessions, listened to 566 presentations and viewed 857 posters. And the sharing of knowledge didn…
For Immediate Release Media Release Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021 New data released on trials involving RNAi therapeutics, antivirals and structurally engineered fatty acids to treat NAFLD Friday 25 June 2021 (Geneva, Switzerland)– Leading …
In EASL Studio, we were honoured to keep company with the three 2020 Nobel Laureates, awarded the 2020 Nobel Prize for Physiology and Medicine for their discovery of the hepatitis C virus. They reflected on many thought-provoking topics: the exponential sophistication of research conditions, bet…
For Immediate Release Media Release Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021 Thursday 24 June 2021 (Geneva, Switzerland)– Leading hepatology researchers announced important new developments in hepatitis research at the International Liver Congress 2021…
For Immediate Release Media Release ILC 2021 opens with focus on impact of COVID-19 on global liver disease New data demonstrates that chronic liver disease increased the odds of COVID-19 death by 80% and Pfizer-BioNTech COVID-19 vaccine confers low immunity on people with advanced liver disease …
Five EU-funded projects to explore at ILC 2021 15 June 2021 EASL is proud to be the communications and dissemination arm for five major EU-funded projects for diagnosing and combating liver disease: A-TANGO, DECISION, LITMUS, Liver-Screen, and MICROB-PREDICT. We spread the news about their devel…
Mark your calendars! On 22 of June 2021, the European Association for the Study of Liver disease (EASL) will be releasing the much-anticipated updated guidelines on the use of non-invasive techniques (NITs). These new guidelines will be presented and discussed in a session available on the ILC …
8 June 2021 EASL is delighted to be officially endorsing International NASH Day 2021: NASH Around the World, conducted by the Global Liver Institute (GLI), this Thursday, 10 June. Non-alcoholic steatohepatitis (NASH), the advanced form of non-alcoholic fatty liver disease (NAFLD), is a life-thre…
Last December, we asked you, as members of the liver community, to tell us which topics you wanted to see featured in the ILC 2021 programme. We received numerous excellent suggestions and we thank you for your help. The Organising Committee has taken your input into consideration and developed a…
31 May 2021 This European Week Against Cancer, EASL has contributed in many ways to tackling liver cancer: signing a joint-society statement, contributing to a White Paper, and taking part in several webinars. Every year, from 25 to 31 May, European Week Against Cancer (#ECAW) is held to unite …
